Thomas B. Cueni is Director General of IFPMA since 1 February 2017. Prior to joining IFPMA he was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland. For many years Thomas Cueni has been involved in the work of the European Federation of Pharmaceutical Industries and Associations, EFPIA, where he most recently served as Vice-Chair of the European Markets Committee and association representative on the Board. He represented the industry on the EU High Level Pharmaceutical Forum, was Chairman of EFPIA’s Economic and Social Policy Committee and Chairman of the EFPIA Task Force on the EU Commission’s Pharmaceutical Sector Inquiry. Thomas Cueni also represented Interpharma, which he successfully transformed from the association of Swiss Rx companies to the association of pharmaceutical research companies in Switzerland, on the Council of IFPMA.
Prior to his appointment with Interpharma, Thomas Cueni had a career as a journalist, inter alia as London correspondent for the “Basler Zeitung” and “Der Bund”, and he served as a Swiss career diplomat with postings in Paris (OECD) and Vienna (IAEA, UNIDO). He studied at the University of Basle, the London School of Economics, and the Geneva Graduate Institute for International Studies, and has Master degrees in economics (University of Basel) and politics (London School of Economics, LSE).

Dr Adshead is responsible for leading and managing NCDA’s strategic and corporate partnerships, and building the supporter base to ensure the organisation’s sustainability. Prior to this, Fiona was BUPA’s Chief Wellbeing and Public Health Officer, responsible for leading work on prevention, behaviour change, workplace health, partnerships, and catalysing Bupa‐wide action on improving the health of the world by creating pathways to make people healthier in a commercially sustainable and globally recognised way. Before joining Bupa, Fiona was Director of Chronic Disease and Health Promotion at the World Health Organization, with five years’ experience as Deputy Chief Medical Officer and Director General in the UK Government, responsible for health improvement and health inequalities. This included responsibility for inequalities, tobacco control, obesity, diet, physical activity, behaviour change and social marketing in relationship to health behaviours. A high profile public health leader with a record of reframing thinking and developing innovative policy and programmes at the heart of government and business. She has worked with business leaders including BiTC, WEF and WBCSD on public health and sustainability issues.

Dr Line Kleinebreil has been working at public hospitals in Paris. She headed the telemedicine unit at Georges Pompidou Hospital from 2005 to 2010. She serves as vice president of UNFM (Université Numérique Francophone Mondiale), in charge of e-learning health programs for French speaking developing countries, with a special interest in diabetes and chronic diseases. She is also Consultant for the Be He@lthy, Be Mobile program led by the International Telecommunication Union (ITU) and the World health Organisation (WHO)

Surabhi is a Technical Officer for the WHO mHealth Secretariat for the joint UN initiative Be He@lthy, Be Mobile. In this position she is responsible for coordinating country implementation and scale-up of mHealth programs for non-communicable diseases. She has previously worked in the Department of Health Statistics and Information Systems at WHO Geneva, International Union for TB and Lung Diseases (The Union) in New Delhi, UNAIDS TSF in Nepal, and the National AIDS Control Organization (NACO), Ministry of Health in New Delhi, India. She holds an MPP from the School of Public Health at Johns Hopkins University, where she was a Fulbright-Nehru Scholar.

Catherine Levy, Head of Global Health Programs for Non-communicable Disease within Sanofi, is in charge of the development and implementation of NCD programs with a specific focus on diabetes & cardiovascular disease.
Pharm D, PhD by training, Catherine has been involved in diabetes for the last 10 years, working closely with emerging countries and developing diabetes access, capacity building and training projects in close partnership with health care providers, patient associations, governments and NGO.
Sanofi has collaborated to several programs such as the KIDs project (in collaboration with the International Diabetes Federation) and Be He@lthy Be Mobile program led by the International Telecommunication Union (ITU) and the World health Organisation (WHO) (with focus in supporting the diabetes pilot in Senegal).